Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
This grant funds the development and translation of innovative medical technologies into clinical practice.
About this program
The Blueprint MedTech Translator grant supports projects that aim to bridge the gap between medical technology development and clinical application. It is designed for researchers and organizations focused on translating cutting-edge medical technologies into practical solutions that can improve patient care. The grant encourages collaboration between technology developers and clinical practitioners to ensure that innovations are effectively integrated into healthcare settings. Eligible applicants include academic institutions, nonprofit organizations, and private companies that are working on projects with a clear clinical application. The grant provides funding to support the necessary research and development activities, as well as the clinical trials that may be required to validate the technologies. By fostering partnerships between various stakeholders in the healthcare ecosystem, this grant aims to accelerate the adoption of new medical technologies that can enhance patient outcomes.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and private companies focused on medical technology.